Biotech

All Articles

James Wilson leaving Penn to introduce two new biotechs

.After much more than thirty years, gene treatment trailblazer James Wilson M.D., Ph.D., is actually...

3 biotechs make an effort to trump the summer heat energy by shedding team

.As biotechs seek to switch a new webpage in August, a minimum of 3 business have lost team in attem...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Expert equity capital firm venBio has actually elevated an additional half a billion bucks to purch...

Otsuka pays $800M for Jnana as well as its clinical-stage PKU medication

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 million so the Japanese biotech...

FibroGen gives up 75% of US staff as asset fails 2 even more trials

.FibroGen is actually drastically restructuring its own service, giving up 75% of its own USA person...

Tracon wane full weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has decided to wane functions weeks after an injectable invulnerable gate pr...

Ideaya bags choice on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on fallen short epilepsy medication, proclaims FDA run

.Our team actually know that Takeda is wanting to discover a road to the FDA for epilepsy medication...

VBI Vaccines files for insolvency, looks for possession sale

.Immunology biotech VBI Vaccinations is turning dangerously close to the point of no return, along w...

Celldex anti-cKIT antibody decrease colonies in one more phase 2 research

.It is actually hard to muscular tissue in on a space as very competitive as immunology, but Celldex...